Login
China Healthcare
- Pininvest Analysis
No one doubts health care in China is becoming an ever bigger story and no one will be surprised to see the Chinese authorities focus doggedly on strengthening the country’s pharmaceutical expertise
With most of the pharmaceutical businesses quoted on Chinese stock markets, American investors may be advised to refer to our theme of US listed companies as informative – but partial – guidelines regarding some of the Chinese health care trends
- Not all the OTC-listed companies appear to be actively traded, though successfully introduced on the Chinese market
- High valuations may in many cases reflect a tendency of the Chinese investors to ‘overshoot’ in a spurt of optimism
The overall growth perspectives, and the will to ensure Chinese companies are the immediate beneficiaries, are unquestionable – foreign providers, such as Novo Nordisk of Denmark NVO/NYSE in the diabetes market, are well aware of the challenge
China Healthcare • Updated:
| Name | Ticker | Exchange | Sector | Industry | Currency | Cur.Price | Mkt.Cap | Perf. | Vol. | Risk Contrib. | MDD |
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BeiGene | BGNE | NASDAQ | Health Care | Gene Editing - Cell Therapies | USD | 189.18 | 15 B | 48.6% | 55% | 4% | -42% |
|
|
| Cellular Biomedicine | CBMG | NASDAQ | Health Care | Biopharmaceuticals | USD | 16.56 | 321 M | 11.8% | 63% | 6% | -39% |
|
|
| Concord Medical Services | CCM | NYSE | Health Care | Healthcare Facilities & Services | USD | 1.65 | 72 M | -27.9% | 86% | 3% | -55% |
|
|
| CSPC Pharmaceutical Group | CHJTF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 1.84 | - | 32.5% | 44% | 1% | -24% |
|
|
| Genscript Biotech | GNNSF | OTC | Health Care | Biopharmaceuticals | USD | 2.00 | - | -18.0% | 45% | 1% | -35% |
|
|
| Guangzhou Baiyunshan Pharmaceutical Holdings | GZPHF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 3.65 | - | -17.0% | 14% | 0% | -17% |
|
|
| Hutchison China MediTech | HCM | NASDAQ | Health Care | Drug Manufacturers -Specialty Pharma | USD | 27.61 | 3.7 B | 25.9% | 60% | 8% | -49% |
|
|
| Novo Nordisk | NVO | NYSE | Health Care | Diabetes | USD | 65.68 | 155 B | 28.8% | 30% | 3% | -24% |
|
|
| Shandong Weigao Group Medical | SHWGY | OTC | Health Care | Medical Consumables & Intermediates | USD | 9.29 | - | 156.3% | 46% | 6% | -17% |
|
|
| Shanghai Fosun Pharmaceutical | SFOSF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 3.56 | - | 20.6% | 51% | 5% | -22% |
|
|
| Shanghai Pharmaceuticals | SHPMY | OTC | Health Care | Drug Manufacturers - Diversified | USD | 8.88 | - | -8.1% | 57% | 4% | -34% |
|
|
| Sihuan Pharmaceutical Holdings | SHPHF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 0.05 | - | -67.0% | 973% | 34% | -100% |
|
|
| Sino Biopharmaceutical | SBMFF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 1.85 | - | 79.1% | 54% | 5% | -26% |
|
|
| Sinopharm Group | SHTDF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 2.57 | - | -23.7% | 47% | 1% | -47% |
|
|
| Tong Ren Tang Technologies | TGRNF | OTC | Health Care | Drug Manufacturers - Diversified | USD | 0.75 | - | -42.3% | 30% | 0% | -44% |
|
|
| WuXi Biologics (Cayman) | WXXWY | OTC | Health Care | Medical Laboratories & Research | USD | 36.50 | - | 92.7% | 45% | 9% | -26% |
|
|
| Zai Lab | ZLAB | NASDAQ | Health Care | Drug Manufacturers -Specialty Pharma | USD | 79.70 | 5.4 B | 118.9% | 58% | 11% | -29% |
|